Peripheral IV Catheters Market Intelligence Report Covers Trends, Segments And Regional Growth

The peripheral IV catheters market is set to experience significant expansion in the coming years, driven by technological advancements and evolving healthcare needs. This industry is evolving rapidly, influenced by new innovations and a shift towards safer, smarter infusion therapies. Let's explore the current market size, key players, influential trends, and detailed segmentation within this growing sector.

Projected Market Size and Expected Growth Trajectory for Peripheral IV Catheters
By 2030, the peripheral IV catheters market is forecasted to reach a value of $9.01 billion, expanding at a compound annual growth rate (CAGR) of 9.4%. Several factors contribute to this growth, including improvements in safety catheter technologies, wider acceptance of smart and antimicrobial catheter variants, and the increasing availability of home healthcare services. Furthermore, there is a rising preference for integrated or closed IV systems as they enhance patient safety and streamline therapy administration. The forecast period also highlights trends such as the adoption of AI-guided catheter insertion systems, cloud-based patient monitoring for IV therapy, innovations in antimicrobial and intelligent catheter designs, the use of IoT-enabled devices for real-time IV monitoring, and the growing implementation of smart manufacturing processes for these devices.

The peripheral iv catheters market size has grown strongly in recent years. It will grow from $5.74 billion in 2025 to $6.29 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to high incidence of hospital-acquired infections, reliance on conventional IV catheters, growing patient population requiring iv, limited availability of advanced safety catheters, fragmented healthcare infrastructure.

Download a free sample of the peripheral iv catheters market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6658&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Propelling Market Expansion in Peripheral IV Catheters
The market is benefiting from significant technological progress that enhances catheter safety and efficiency. Advancements in catheter design reduce infection risks and improve ease of use, making them increasingly preferred in various healthcare settings. These innovations are crucial, especially as healthcare providers seek to improve patient outcomes and reduce complications related to IV therapy.

Another important driver is the rapid growth of home healthcare services worldwide. As more patients receive care outside traditional hospital environments, demand for user-friendly and reliable IV catheter systems continues to rise. This expansion supports the adoption of integrated and closed systems that offer better infection control and ease of management in non-clinical settings.

View the full peripheral iv catheters market report:
https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Who Leads the Peripheral IV Catheters Market?
The peripheral IV catheters market features several dominant players, including:
- Becton, dic*kinson and Company
- B. Braun Melsungen AG
- Smiths Medical Inc.
- Vygon SAS
- Terumo Corporation
- Teleflex Incorporated
- NIPRO Medical Corporation
- Argon Medical Devices Inc.
- Medical Components Inc.
- Vascular Pathways Inc.
- Tangent Medical Technologies Inc.
- Vigmed AB
- Venner Medical
- C. R. Bard Inc.
- MedSource Labs
- Intra Special Catheters GmbH
- Greiner Bio-One International GmbH
- Ares Medikal
- Ace Medical Company
- Heka s.r.l
- Raumedic AG
- Vogt Medical Vertrieb GmbH
- RenovoRx Inc.
- Retractable Technologies Inc.
- AngioDynamics Inc.
- ICU Medical Inc.
- Medtronic plc
- Edwards Lifesciences Corporation
- Cook Group Incorporated
- Stryker Corporation
- Boston Scientific Corporation
- Johnson & Johnson
- Abbott Laboratories
- Merit Medical Systems Inc.

A significant development occurred in May 2025 when ICU Medical Inc., a US-based manufacturer of vascular-access devices, collaborated with Otsuka Pharmaceutical Factory Inc. to strengthen the IV solutions and infusion therapy market. This partnership established Otsuka ICU Medical LLC, merging OPF's expansive IV solutions manufacturing facilities across Asia (16 production sites) with ICU Medical's North American production and distribution prowess. The joint venture aims to enhance supply chain resilience, ensure large-scale and steady IV solutions availability, and introduce innovative PVC-free IV technologies to North America, ultimately supporting growth in peripheral IV and infusion therapy markets. Otsuka Pharmaceutical Factory Inc. is a notable Japanese company specializing in IV solutions and related therapy products.

Innovations and Emerging Trends Boosting the Peripheral IV Catheters Sector
Key industry players are focused on pioneering products that improve both patient safety and clinical workflow. One such innovation is the multi-access blood control septum, a valve integrated into the catheter hub that permits multiple connections without blood leakage and eliminates the need for manual vein occlusion. This advancement maintains a closed system, enhancing safety for healthcare providers.

For example, in July 2024, Germany-based B. Braun Melsungen AG announced that the FDA approved its Introcan Safety® 2 Deep Access IV Catheter featuring this multi-access blood control septum. This product is specifically engineered to prevent blood leakage during hub access, remove the necessity for manual vein occlusion, and reduce contamination risks during repeated connections and disconnections in IV therapy.

Segment Analysis and Market Distribution in the Peripheral IV Catheters Industry
The peripheral IV catheters market is categorized into key segments as follows:

1) Product Type:
- Short Peripheral Intravenous Catheters
- Integrated or Closed Peripheral Intravenous Catheters (PIVC)

2) Technology:
- Conventional Peripheral Intravenous Catheters (PIVC)
- Safety Peripheral Intravenous Catheters (PIVC)

3) End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Healthcare

Further breakdowns within these categories include:
- Short Peripheral Intravenous Catheters: Over-the-Needle Catheters, Winged Infusion Sets
- Integrated or Closed Peripheral Intravenous Catheters: Safety Catheters, Antimicrobial Catheters, Smart Catheters

This segmentation provides a detailed view of market dynamics, showcasing the variety of products tailored to different clinical requirements and settings, which helps explain the robust growth prospects forecasted through 2030.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.